AstraZeneca Statistics

Total Valuation

AstraZeneca has a market cap or net worth of ARS 410.05 trillion. The enterprise value is 444.01 trillion.

Market Cap	410.05T
Enterprise Value	444.01T

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	Feb 20, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	68.01%
Float	1.54B

Valuation Ratios

The trailing PE ratio is 27.63 and the forward PE ratio is 18.27.

PE Ratio	27.63
Forward PE	18.27
PS Ratio	4.81
PB Ratio	5.80
P/TBV Ratio	n/a
P/FCF Ratio	24.01
P/OCF Ratio	19.38
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.97, with an EV/FCF ratio of 26.00.

EV / Earnings	29.92
EV / Sales	5.35
EV / EBITDA	15.97
EV / EBIT	21.99
EV / FCF	26.00

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.61.

Current Ratio	0.94
Quick Ratio	0.65
Debt / Equity	0.61
Debt / EBITDA	1.51
Debt / FCF	2.52
Interest Coverage	10.47

Financial Efficiency

Return on equity (ROE) is 22.84% and return on invested capital (ROIC) is 16.48%.

Return on Equity (ROE)	22.84%
Return on Assets (ROA)	8.19%
Return on Invested Capital (ROIC)	16.48%
Return on Capital Employed (ROCE)	17.12%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	887.14M
Profits Per Employee	154.43M
Employee Count	96,100
Asset Turnover	0.54
Inventory Turnover	1.81

Taxes

In the past 12 months, AstraZeneca has paid 3.15 trillion in taxes.

Income Tax	3.15T
Effective Tax Rate	17.49%

Stock Price Statistics

The stock price has increased by +67.87% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+67.87%
50-Day Moving Average	72,674.50
200-Day Moving Average	63,443.63
Relative Strength Index (RSI)	41.04
Average Volume (20 Days)	243

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AstraZeneca had revenue of ARS 85.25 trillion and earned 14.84 trillion in profits. Earnings per share was 9,492.16.

Revenue	85.25T
Gross Profit	69.66T
Operating Income	20.74T
Pretax Income	18.00T
Net Income	14.84T
EBITDA	27.98T
EBIT	20.74T
Earnings Per Share (EPS)	9,492.16

Balance Sheet

The company has 8.30 trillion in cash and 43.11 trillion in debt, giving a net cash position of -34,810.38 billion.

Cash & Cash Equivalents	8.30T
Total Debt	43.11T
Net Cash	-34,810.38B
Net Cash Per Share	n/a
Equity (Book Value)	70.71T
Book Value Per Share	45,544.47
Working Capital	-2,748.95B

Cash Flow

In the last 12 months, operating cash flow was 21.15 trillion and capital expenditures -4,078.43 billion, giving a free cash flow of 17.08 trillion.

Operating Cash Flow	21.15T
Capital Expenditures	-4,078.43B
Depreciation & Amortization	7.01T
Net Borrowing	-2,840.47B
Free Cash Flow	17.08T
FCF Per Share	n/a

Margins

Gross margin is 81.71%, with operating and profit margins of 24.33% and 17.41%.

Gross Margin	81.71%
Operating Margin	24.33%
Pretax Margin	21.11%
Profit Margin	17.41%
EBITDA Margin	32.82%
EBIT Margin	24.33%
FCF Margin	20.03%

Dividends & Yields

This stock pays an annual dividend of 985.99, which amounts to a dividend yield of 1.38%.

Dividend Per Share	985.99
Dividend Yield	1.38%
Dividend Growth (YoY)	40.91%
Years of Dividend Growth	4
Payout Ratio	47.39%
Buyback Yield	0.06%
Shareholder Yield	1.45%
Earnings Yield	3.62%
FCF Yield	4.16%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AstraZeneca has an Altman Z-Score of 3.24 and a Piotroski F-Score of 7.

Altman Z-Score	3.24
Piotroski F-Score	7